This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

US Prescription Medical Food Company Appoints Board Of International Advisors

SCOTTSDALE, Ariz., April 10, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based, emerging pharmaceutical company specializing in prescription Medical Foods, today announced the appointment of a number of International Advisors to its International Commercial Advisory Board.  Board members will act as a "sounding board" for Prismic's senior management and Board of Directors in terms of providing input and opinions regarding pharmaceutical/healthcare industry developments, latest trends and practices on a local and international basis.  Recently appointed advisors include: 

  • Antoni Esteve, Ph.D., ( Spain) who is a member of the Board of Directors of Laboratorios del Dr. Esteve, S.A., one of Spain's largest pharmaceutical and chemical manufacturing companies with operations in 40 countries and a presence in more than 60.  
  • Cosimo Pulli , Ph.D., ( Italy) who serves as the senior executive responsible for Emerging Markets at Chiesi Farmaceutici Spa, one Italy's major pharmaceutical companies and the leader in R&D investment.  
  • Massimo Bonsi, ( Eastern Europe) who is the Founder and CEO of the Solartium Group based in Bucharest, Romania, and who has significant pharmaceutical industry knowledge and expertise in the Eastern European region.
  • Anthony H. Wild , Ph.D., (International) the former President of Warner-Lambert's Parke-Davis global Pharmaceutical business.  Currently, Dr. Wild is a member of the Board of Directors of Ranbaxy Laboratories and several privately-owned specialty pharmaceutical companies. He also is on the board of advisors of Auven Therapeutics, a pharmaceutical venture fund. 

Additionally, Prismic has appointed  Marco Cartolari, the founder and, until its recent acquisition, CEO of Scharper SpA, as a Special Advisor to the Board of Directors. Under Cartolari's leadership, Scharper pioneered the development of nutraceuticals and highly scientific "medical food" type products in Italy, and promoted/detailed those products to physicians via Scharper's own sales force

Commenting on these appointments, Peter Moriarty, the Chairman and CEO of Prismic Pharmaceuticals stated, "Prismic is honored to have such a distinguished group of International Advisors.  Their pharmaceutical industry knowledge and perspectives will be of great value to our senior management team and our Board of Directors."

About Prismic Pharmaceuticals, Inc. Prismic Pharmaceuticals, Inc., is a privately held pharmaceutical company focused on the development and marketing of prescription medical foods for the clinical dietary management of the metabolic processes associated with many of the disorders associated with the aging population, particularly where inflammation is involved.  The company is based in Scottsdale, Arizona, and was founded in 2011. Contact 480.422.1810 or visit www.PrismicPharma.com .

INFORMATION CONTACT: Peter MoriartyTel: 480.422.1810

SOURCE Prismic Pharmaceuticals, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs